Mild Cognitive Impairment Clinical Trial
Official title:
Imaging the Neural Network Connectivity on Patients With Mild Cognitive Impairment
The hypothesis tested if the diffusion properties in the base line, such as mean diffusivity
or kurtosis, can differentiate two subtypes of MCI and predict the clinical outcome in
Patients. The hypothesis further supports the correlation of the measured diffusion
properties and the disease severity. We therefore proposed to investigate the potential value
of diffusion properties as a possible tool to monitor the disease progression. The disease
related changes in neural connectivity will be investigated.
1. The diffusion MRI could provide an improved diagnosis of Alzheimer's Disease and Mild
cognitive Impairment.
Explanation:
The deposition of the macromolecules such as beta amyloid in the brain and the
associated neuron death of the patient could lead to observable changes in tissue
microenvironment. The related changes would lead to alterations in either the amplitude
or distribution of water diffusion. In turn it could be detected in diffusion tensor and
kurtosis.
2. aMCI is a preclinical state of AD and dMCI is from a different etiology, which can be
differentially diagnosis by MRI. Diffusion Imaging could help to predict the clinical
outcome Explanation
Mild Cognitive Impairment (MCI) referred to a decline of cognition in elder adults that are
not of sufficient magnitude to meet the criteria for dementia. It is usually regarded as a
transition state between patients of Alzheimer's Disease (AD) and the age matched healthy
adults. It is a heterogeneous syndrome which can be divided into two subtypes: amnestic and
dysexecutive. This 3 year proposal continues from a NSc funded project, in which we reported
that the amnestic MCI could involve global white matter changes and therefore could be a
preclinical status to AD. In contrast, no compromise in white matter status was found in
patients of dysexecutive MCI. Therefore we proposed to further investigate the phenomena in
this project.
The subjects will be divided into 3 groups: 30 patients with amnestic MCI, 30 with
dysexecutive MCI and 30 healthy age-matched normal controls. Comprehensive neuropsychological
examinations will be performed after detailed clinical history and physical screening,
including Mini-Mental Status Examination, Clinical Dementia Rating and the Cognitive
Abilities Screening Instrument. Successful candidate will be examined by 3T MRI, including
diffusion imaging and high resolution T1 weighted anatomical images.
The current project proposed to examine the sensitivity and specificity of diffusion Magnetic
Resonance Imaging, in the diagnosis of MCI and differential diagnosis of two subtypes. Both
the conventional tensor derived indices and diffusion kurtosis will be compared. This is due
to the fact that in a recently publication in Radiology, we reported an improved diagnostic
performance on neurodegenerative disease from diffusion kurtosis than diffusion tensor.
Secondly we will examine the regional changes of diffusion properties and correlated with the
white matter involvement in patients. High resolution track density images will be
implemented and compared with the susceptibility weighted imaging in an effort to address the
underlying changes in pathophysiology. In the third year, the prognostic value of diffusion
MRI will be determined. The optimal cutoff value of diffusion MRI in the prediction of
conversion to Alzheimer's disease will be reported. The diffusion properties in patients with
early conversion (the 2nd year) and late conversion (the 3rd year) will be compared.
It is expected that changes in diffusion can be used as an image based surrogate marker
during the neurodegenerative process. The new insight into the temporal evolution of the
diffusion MRI might help to understand the underlying etiology and pathophysiology between
the amnestic and dysexecutive MCI patients, which can contribute to an early intervention
strategy and might ultimately lead to an effective treatment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |